Article L5124-17
Pharmaceutical companies and establishments may only be advertised in accordance with the conditions laid down by regulation.
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 1061–1070 of 24360 articles for “Art. 155 IV”
Pharmaceutical companies and establishments may only be advertised in accordance with the conditions laid down by regulation.
When the wholesaler-distributor has fulfilled its public service obligations as set out in article L. 5124-17-2, it may sell medicinal products outside the national territory or to wholesale distribut…
A proprietary medicinal product subject to parallel distribution is a proprietary medicinal product : 1° Has a marketing authorisation issued by the European Union pursuant to Regulation (EC) No 726/2…
…ble pharmacists. They are personally liable for compliance with the provisions relating to their activity, without prejudice, where applicable, to the joint and several liability of the company. In ea…
…in the meaning of the previous paragraph. The authorisation provided for in article L. 1123-8 is equivalent to an import authorisation for any medicinal product required to carry out the authorised re…
The pharmacist in charge and the delegated pharmacists must practise their profession personally.They must be assisted and, in the event of temporary absence or if they are banned from practising, the…
Non-profit humanitarian organisations may have a pharmaceutical establishment, which they own, which wholesales medicinal products to similar organisations with the same purpose in France or in a Stat…
Subject to the provisions ofOrder no. 2014-948 of 20 August 2014 relating to the governance and capital transactions of publicly held companies, "Laboratoire français du fractionnement et des biotechn…
…111-4. Marketing may not be discontinued before the end of the period required to introduce alternative solutions to cover this need. If the medicinal product is not a medicinal product of major thera…
The activities referred to in Article L. 5124-1 may be carried out by pharmaceutical establishments set up within non-profit organisations or public establishments other than health establishments: 1°…
Our translations are produced and reviewed for accuracy, but the only legally binding version of French law is the French original. For court, registry or contractual use we offer lawyer-reviewed or sworn certified translations on request.
Articles are synced with Légifrance and updated as soon as a reform is published in the Journal Officiel, so you always read the version in force — and can see when each article was last amended.
Each article is linked to the key court decisions (Cour de cassation, Conseil d'État, courts of appeal) that interpret it, so you can read the text and its case-law application side by side.
Yes — every article has an AI plain-English summary, and you can order a lawyer-reviewed explanation of how it applies to your specific situation, with next steps.
No. Reading and searching the codes is free with no login. Paid services — certified translation and the legal application report — are entirely optional.
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More